ABVC BioPharma's total assets for Q3 2025 were $21.18M, an increase of 30.39% from the previous quarter. ABVC total liabilities were $6.68M for the fiscal quarter, a -1.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.